Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Nicotine induces cell proliferation by β-arrestin–mediated activation of Src and Rb–Raf-1 pathways
Piyali Dasgupta, … , Eric Haura, Srikumar Chellappan
Piyali Dasgupta, … , Eric Haura, Srikumar Chellappan
Published August 1, 2006
Citation Information: J Clin Invest. 2006;116(8):2208-2217. https://doi.org/10.1172/JCI28164.
View: Text | PDF | Corrigendum
Research Article Oncology Article has an altmetric score of 6

Nicotine induces cell proliferation by β-arrestin–mediated activation of Src and Rb–Raf-1 pathways

  • Text
  • PDF
Abstract

Recent studies have shown that nicotine, a component of cigarette smoke, can stimulate the proliferation of non-neuronal cells. While nicotine is not carcinogenic by itself, it has been shown to induce cell proliferation and angiogenesis. Here we find that mitogenic effects of nicotine in non–small cell lung cancers (NSCLCs) are analogous to those of growth factors and involve activation of Src, induction of Rb–Raf-1 interaction, and phosphorylation of Rb. Analysis of human NSCLC tumors show enhanced levels of Rb–Raf-1 complexes compared with adjacent normal tissue. The mitogenic effects of nicotine were mediated via the α7-nAChR subunit and resulted in enhanced recruitment of E2F1 and Raf-1 on proliferative promoters in NSCLC cell lines and human lung tumors. Nicotine stimulation of NSCLC cells caused dissociation of Rb from these promoters. Proliferative signaling via nicotinic acetylcholine receptors (nAChRs) required the scaffolding protein β-arrestin; ablation of β-arrestin or disruption of the Rb–Raf-1 interaction blocked nicotine-induced proliferation of NSCLCs. Additionally, suppression of β-arrestin also blocked activation of Src, suppressed levels of phosphorylated ERK, and abrogated Rb–Raf-1 binding in response to nicotine. It appears that nicotine induces cell proliferation by β-arrestin–mediated activation of the Src and Rb–Raf-1 pathways.

Authors

Piyali Dasgupta, Shipra Rastogi, Smitha Pillai, Dalia Ordonez-Ercan, Mark Morris, Eric Haura, Srikumar Chellappan

×

Figure 1

Nicotine induces Rb inactivation and S-phase entry in lung cells.

Options: View larger image (or click on image) Download as PowerPoint
Nicotine induces Rb inactivation and S-phase entry in lung cells.
(A) Ni...
(A) Nicotine induces S-phase entry. Quiescent H23, H441, H226, and A549 cells were treated with 1 μM nicotine for 18 hours in the presence or absence of a panel of nAChR subunit inhibitors. hex, hexamethonium bromide; α-BT, α-bungarotoxin. (B) A similar experiment was performed using normal lung cells, namely NHBEs, SAECs, and HMEC-Ls. (C) Transfection of α7-nAChR siRNA ablated the mitogenic activity of nicotine on A549 cells, whereas a nontargeting control siRNA had no effect. (D) Western blotting analysis showed that α7-nAChR siRNA ablated the expression of α7-nAChR in A549 cells, which was quantitated using densitometric analysis. A nontargeting siRNA sequence was used as a control for all experiments. (E) An in vitro assay using full-length Rb as a substrate to measure cyclin D–associated kinase activity in quiescent and nicotine-stimulated A549 cells. The lower panel shows a Coomassie Blue staining of the gel indicating comparable amounts of substrate in all lanes. (F) A similar assay as in E, showing cyclin E–associated kinase activity using histone H1 as a substrate. (G) Nicotine induces the dissociation of E2F1 from Rb in A549 cells, with concomitant phosphorylation of Rb. WB, Western blot. (H) Nicotine caused increased recruitment of E2F1 on the E2F-responsive cdc6 promoter and cdc25A accompanied by concomitant dissociation of Rb. PCR for the c-Fos promoter was taken as the negative control.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Referenced in 2 patents
83 readers on Mendeley
See more details